Kistler-Tiffany Companies’s PhaseBio Pharmaceuticals, Inc. Common Stock PHAS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-300
| Closed | – | – | 852 |
|
2022
Q3 | $0 | Hold |
300
| – | – | ﹤0.01% | 835 |
|
2022
Q2 | $0 | Hold |
300
| – | – | ﹤0.01% | 806 |
|
2022
Q1 | $0 | Hold |
300
| – | – | ﹤0.01% | 784 |
|
2021
Q4 | $1K | Hold |
300
| – | – | ﹤0.01% | 723 |
|
2021
Q3 | $1K | Hold |
300
| – | – | ﹤0.01% | 730 |
|
2021
Q2 | $1K | Hold |
300
| – | – | ﹤0.01% | 723 |
|
2021
Q1 | $1K | Hold |
300
| – | – | ﹤0.01% | 664 |
|
2020
Q4 | $1K | Hold |
300
| – | – | ﹤0.01% | 642 |
|
2020
Q3 | $1K | Hold |
300
| – | – | ﹤0.01% | 627 |
|
2020
Q2 | $1K | Hold |
300
| – | – | ﹤0.01% | 583 |
|
2020
Q1 | $2K | Hold |
300
| – | – | ﹤0.01% | 545 |
|
2019
Q4 | $2K | Hold |
300
| – | – | ﹤0.01% | 551 |
|
2019
Q3 | $1K | Hold |
300
| – | – | ﹤0.01% | 581 |
|
2019
Q2 | $4K | Buy |
+300
| New | +$4K | ﹤0.01% | 526 |
|